BiotechTube
Home/Braizon Therapeutics/Philip Davy
PD

Philip Davy

President & CEO, Global Head of Business Development

Braizon Therapeutics

Therapeutic Areas

Neuroscience

Braizon Therapeutics Pipeline

DrugIndicationPhase
Brain Access® PlatformCNS Disorders (Platform)Preclinical
Needs-focused PipelineUndisclosed CNS DisordersPreclinical

Leadership Team at Braizon Therapeutics

MT
Mariko Tosu
Founder and Chairperson
FW
Fumikazu Wanibuchi
Vice President of Clinical Development
MC
Masato Chiba
Vice President of Development Promotion
View full Braizon Therapeutics profile